SSR2 Promotes Sorafenib Resistance Via Interacting with GPX4 to Inhibit Ferroptosis

Zebing Song1, Mengdan Zhou1, Xiaodong Song1

  • 1Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Guangzhou Medical University. Guangzhou 510000, P.R. China.

PubMed
Abstract

Insights

Signal sequence receptor subunit 2 (SSR2) promotes sorafenib resistance in hepatocellular carcinoma (HCC) by inhibiting ferroptosis. Targeting SSR2 may offer a new therapeutic strategy for HCC patients resistant to sorafenib.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Sorafenib is a key first-line treatment for hepatocellular carcinoma (HCC).
  • Understanding mechanisms of sorafenib resistance is crucial for improving HCC treatment outcomes.
  • Signal sequence receptor subunit 2 (SSR2) has emerged as a potential factor in cancer progression.

Purpose of the Study:

  • To investigate the role of SSR2 in sorafenib resistance in HCC.
  • To elucidate the molecular mechanisms underlying SSR2-mediated sorafenib resistance.

Main Methods:

  • Cell viability assays (MTT, colony formation) to assess SSR2's impact on sorafenib resistance.
  • Co-immunoprecipitation (CoIP) to identify SSR2 interacting proteins.
  • Functional assays to explore SSR2's effect on ferroptosis and its interaction with GPX4.

Main Results:

  • SSR2 was found to be upregulated in sorafenib-resistant HCC tissues and associated with poor clinical outcomes.
  • SSR2 overexpression promoted sorafenib resistance in HCC cells by suppressing ferroptosis.
  • SSR2 was shown to interact with glutathione peroxidase 4 (GPX4), enhancing its activity and inhibiting ferroptosis.

Conclusions:

  • SSR2 plays a significant role in the development of sorafenib resistance in HCC.
  • Targeting the SSR2-GPX4 interaction and its effect on ferroptosis presents a potential therapeutic strategy for overcoming sorafenib resistance in HCC.

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

3.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K